Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Ready to Explore Your Options
Hypoglycemia is a theoretical concern given MOTS-c's insulin-sensitizing effects, particularly in patients already using insulin, sulfonylureas, or other glucose-lowering agents
Potential Key Benefits*: Encourages enhanced immune system function Supports improved resistance to infections Supports Balanced inflammatory response May increase energy and vitality Supports better stress resilience Made in America in a cGMP Facility Questions or Concerns
It is intended to be administered by intramuscular injection
KD was shown to slow tumor growth in immunocompromised mice that had genetically and metabolically differentiated melanoma xenografts, indicating that it can inhibit tumor progression regardless of the genetic basis of the tumors
Prepare syringe: draw air into the syringe equal to your dose, then pull the peptide solution from the vial
